Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2010
11/03/2010EP2246345A1 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/03/2010EP2246344A1 Pyrimidine compounds and medicinal composition thereof
11/03/2010EP2246335A1 Aminopyridineamides as pesticides
11/03/2010EP2246333A1 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
11/03/2010EP2246330A1 New photoinitiators
11/03/2010EP2246329A1 4(1H)-pyridinone derivatives and their use as antimalaria agents
11/03/2010EP2245025A1 Carboxamide-heteroaryl derivatives for the treatment of diabetes
11/03/2010EP2245017A2 Novel heterocycles
11/03/2010EP2245014A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
11/03/2010EP2029572B1 Organic compounds
11/03/2010EP2001855B1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
11/03/2010EP1966188B1 Enantioselective preparation of benzimidazole derivatives and their salts
11/03/2010EP1863477B1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
11/03/2010EP1646622B1 Tacrine derivatives as inhibitors of acetylcholinesterase
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP1485093B1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
11/03/2010EP1220838B1 1-aziridino-1-hydroxyiminomethyl-derivatives, method for the production thereof and medicaments containing said compounds
11/03/2010CN101878209A Oxypiperidine derivatives and methods of use thereof
11/03/2010CN101878208A Substituted-quinoxaline-type-piperidine compounds and the uses thereof
11/03/2010CN101878203A Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
11/03/2010CN101878200A Indoline compounds
11/03/2010CN101878199A 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
11/03/2010CN101878031A Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
11/03/2010CN101875961A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related therto
11/03/2010CN101875653A Preparation and application of 1,2,3-3H pyridine-heterocyclic compound
11/02/2010US7825256 Inducible nitric oxide synthase dimerization inhibitors
11/02/2010US7825255 Adenosine receptor selective modulators
11/02/2010US7825248 Synthetic nanopores for DNA sequencing
11/02/2010US7825247 an N-phenyl-4-(4-methyl-piperazin-1-ylmethyl)-benzamide claimed intermediate easily prepared by amidation of the aniline and the benzoic acid; reaction with a 2-aminopyrimidine to produce antitumor tyrosine kinase inhibitor
11/02/2010US7825155 Oxindole derivative as feeding control agent
11/02/2010US7825152 Organic compounds and their uses
11/02/2010US7825140 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
11/02/2010US7825139 Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
11/02/2010US7825138 Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
11/02/2010US7825131 Quinoline potassium channel inhibitors
11/02/2010US7825128 such as N-(ethoxycarbonyl)-S-(4-{[4-{[(R)-2-hydroxy-1-methylethyl]amino}-5-(2-thienyl)pyrimidine-2-yl]amino}phenyl)-S-methylsulfoximide, used for the treatment of breast cancer and rheumatoid arthritis
11/02/2010US7825125 Amorphous aripiprazole and process for the preparation thereof
11/02/2010US7825124 Indolylmaleimide derivatives
11/02/2010US7825122 Diaza heterocyclic sulfonamide derivatives and their uses
11/02/2010US7825119 Bone disorders such as osteoporosis, tumors and cardiovascular disorders; 4-(2-carboxy-2-Boc-aminoethylamino)-6-piperidinopyrimidines such as tert-butyl 2-benzyloxycarbonylamino-3-[2,5-dimethoxy-6-(4-[1,8]naphthyridin-2-yl-piperidin-1-yl)pyrimidin-4-ylamino]-propionate
11/02/2010US7825115 Protein kinase inhibitors; antitumor agents; such as 5-methyl-1-quinol-4-ylmethyl-3-(4-trifluoromethanesulfonylphenyl)imidazolidine-2,4-dione trifluoroacetate
11/02/2010US7825068 Heterocyclylethylcarboxamide derivatives
11/02/2010US7824928 sulfoalkyl substituents and/or hydrophilic linkers derived from homocysteic acid, cysteic acid, glycine peptides, tetraethylene oxide offset hydrophobicity of the acridinium ring system for a more soluble label attached to an antibody at higher loading to prevent protein precipitation and aggregation
11/02/2010CA2545527C Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
11/02/2010CA2460121C 3-substituted-4-pyrimidone derivatives
11/02/2010CA2451798C Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
11/02/2010CA2450581C Cardiovascular safety assay
11/02/2010CA2413971C Heterocyclic hydrazones as novel anti-cancer agents
11/02/2010CA2400167C Insecticidal anthranilamides
11/02/2010CA2389681C Npy y5 antagonist
11/02/2010CA2311456C Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/2010
10/28/2010WO2010124121A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
10/28/2010WO2010124119A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124116A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124114A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124108A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124102A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124086A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124047A1 Bisaryl alkynylamides as negative allosteric modulators of metabotropic glutamate receptor 5 (mglur5)
10/28/2010WO2010123792A1 Preparation of c-pyrazine-methylamines
10/28/2010WO2010123766A1 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
10/28/2010WO2010123451A1 Sulphide bridged derivatives as modulators of mglur5
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123017A1 Tetrazole compound
10/28/2010WO2010123006A1 Pyrrolidine compound
10/28/2010WO2010122980A1 Novel thyroid hormone β receptor agonist
10/28/2010WO2010122340A2 Process 738
10/28/2010WO2010122171A1 5-heteroarylmethyl-i- (b-mercapto- [1,2, 4 -triazolylmethyl) -cyclopentanol as fungicides
10/28/2010WO2010122151A1 3 -azabicyclo [4.1.0] heptanes used as orexin antagonists
10/28/2010WO2010122069A1 5-alkynyl-pyridines
10/28/2010WO2010121918A1 Proline derivatives as cathepsin inhibitors
10/28/2010WO2010093849A3 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
10/28/2010WO2010035283A3 Novel compounds for producing substituted sulfoxides, process for producing the same and use thereof
10/28/2010WO2009118765A3 Novel monoamine re-uptake inhibitor
10/28/2010US20100274016 Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273833 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors
10/28/2010US20100273831 Fluoro alkyl substituted benzimidazole cannabinoid agonists
10/28/2010US20100273830 Novel insecticides
10/28/2010US20100273828 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
10/28/2010US20100273827 OXADIAZOLE DERIVATIVES ACTIVE ON SPHINGOSINE-1-PHOSPHATE (S1p)
10/28/2010US20100273814 ((phenyl)imidazolyl)methylheteroaryl compounds
10/28/2010US20100273808 Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
10/28/2010US20100273805 Sulphide bridged derivatives as modulators of mglur5 733
10/28/2010US20100273799 Small molecule inhibitors of mdm2 and the uses thereof
10/28/2010US20100273795 Arylsulfonamide ccr3 antagonists
10/28/2010US20100273794 Benzimidazolone Compounds Having 5-HT4 Receptor Agonistic Activity
10/28/2010US20100273784 Fused ring heterocycles as potassium channel modulators
10/28/2010US20100273782 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273781 Cxcr3 receptor antagonists
10/28/2010US20100273774 Indolymaleimide derivatives
10/28/2010US20100273772 Bisaryl Alkynylamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 (MGLUR5)
10/28/2010US20100273766 Substituted oxindol derivatives, medicaments containing said derivatives and use thereof
10/28/2010US20100273764 Inhibitors of pi3 kinase and/or mtor
10/28/2010US20100273757 Pyrazine derivatives useful as adenosine receptor antagonists
10/28/2010US20100273755 Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
10/28/2010US20100273724 Pegylated ion channel modulating compounds
10/28/2010US20100273653 Use of Compounds Having a Mongalactosydiacylglycerol Syhnthase Inhibitory Activity as Herbicide or Algaecide, Herbicide and Algaecide Compositions
10/28/2010US20100272677 Heterocyclic antiviral compounds
10/28/2010CA2759714A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 1080